Sudan Ebola virus (SUDV) outbreak in Uganda, 2022: lessons learnt and future priorities for sub-Saharan Africa.
作者信息
Bwire Godfrey, Sartorius Benn, Guerin Philippe, Tegegne Merawi Aragaw, Okware Sam I, Talisuna Ambrose O
机构信息
Division of Public Health Emergency Preparedness and Response, Ministry of Health, Kampala, Uganda.
Department of Community Health and Behavioural Sciences, Makerere University School of Public Health, Kampala, Uganda.
出版信息
BMC Med. 2023 Apr 13;21(1):144. doi: 10.1186/s12916-023-02847-1.
Abstract
摘要
相似文献
1
Sudan Ebola virus (SUDV) outbreak in Uganda, 2022: lessons learnt and future priorities for sub-Saharan Africa.
BMC Med. 2023 Apr 13;21(1):144. doi: 10.1186/s12916-023-02847-1.
2
Lessons Learned from Sudan Ebola Virus Disease (SUDV) Preparedness in Rwanda: A Comprehensive Review and Way Forward.
J Epidemiol Glob Health. 2023 Sep;13(3):528-538. doi: 10.1007/s44197-023-00133-0. Epub 2023 Jun 28.
3
Ebola viral hemorrhagic disease outbreak in West Africa- lessons from Uganda.
Afr Health Sci. 2014 Sep;14(3):495-501. doi: 10.4314/ahs.v14i3.1.
4
The Outbreak of the Ebola Virus: Sudan Strain in Uganda and its Clinical Management.
Prehosp Disaster Med. 2022 Dec;37(6):860-862. doi: 10.1017/S1049023X22002199. Epub 2022 Nov 15.
5
Molecular characterization of the 2022 Sudan virus disease outbreak in Uganda.
J Virol. 2023 Oct 31;97(10):e0059023. doi: 10.1128/jvi.00590-23. Epub 2023 Sep 26.
6
Immune memory to Sudan virus: comparison between two separate disease outbreaks.
Viruses. 2015 Jan 6;7(1):37-51. doi: 10.3390/v7010037.
7
Notes from the Field: Outbreak of Ebola Virus Disease Caused by Sudan ebolavirus - Uganda, August-October 2022.
MMWR Morb Mortal Wkly Rep. 2022 Nov 11;71(45):1457-1459. doi: 10.15585/mmwr.mm7145a5.
8
Sudan virus disease outbreak in Uganda in 2022: the case of patient zero.
Int J Infect Dis. 2023 Mar;128:318-320. doi: 10.1016/j.ijid.2023.01.008. Epub 2023 Jan 12.
9
Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001).
Int J Infect Dis. 2004 Jan;8(1):27-37. doi: 10.1016/j.ijid.2003.04.001.
10
Delayed treatment of cynomolgus macaques with a FVM04/CA45 monoclonal antibody cocktail provides complete protection against lethal Sudan virus infection.
J Virol. 2024 Aug 20;98(8):e0124223. doi: 10.1128/jvi.01242-23. Epub 2024 Jul 16.
引用本文的文献
1
Long-term clinical sequelae among Sudan ebolavirus disease survivors 2 years post-infection: a matched cohort study.
BMC Med. 2025 Jul 18;23(1):432. doi: 10.1186/s12916-025-04271-z.
2
Severe long-term clinical sequelae among Sudan ebolavirus disease survivors 2 years post-infection.
Res Sq. 2025 Apr 17:rs.3.rs-6325522. doi: 10.21203/rs.3.rs-6325522/v1.
3
Barriers to community engagement during the response to an Ebola virus disease outbreak in Uganda.
BMJ Glob Health. 2025 Mar 11;10(3):e017285. doi: 10.1136/bmjgh-2024-017285.
4
Perceived drivers of the Ebola virus disease outbreak in Mubende and Kassanda districts, Uganda: a qualitative study.
BMJ Public Health. 2024 Dec 10;2(2):e001267. doi: 10.1136/bmjph-2024-001267. eCollection 2024 Dec.
5
Filovirus vaccines as a response paradigm for emerging infectious diseases.
NPJ Vaccines. 2024 Oct 11;9(1):186. doi: 10.1038/s41541-024-00985-y.
6
Enabling laboratory readiness and preparedness for the evaluation of suspected viral hemorrhagic fevers: development of a laboratory toolkit.
Infect Control Hosp Epidemiol. 2024 Oct 11;45(9):1-7. doi: 10.1017/ice.2024.143.
7
Development of a Crystallographic Screening to Identify Sudan Virus VP40 Ligands.
ACS Omega. 2024 Jul 18;9(30):33193-33203. doi: 10.1021/acsomega.4c04829. eCollection 2024 Jul 30.
8
Viruses of free-roaming and hunting dogs in Uganda show elevated prevalence, richness and abundance across a gradient of contact with wildlife.
J Gen Virol. 2024 Jul;105(7). doi: 10.1099/jgv.0.002011.
9
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.
PLoS Pathog. 2024 Apr 11;20(4):e1012134. doi: 10.1371/journal.ppat.1012134. eCollection 2024 Apr.
10
Design of universal Ebola virus vaccine candidates via immunofocusing.
Proc Natl Acad Sci U S A. 2024 Feb 13;121(7):e2316960121. doi: 10.1073/pnas.2316960121. Epub 2024 Feb 6.
本文引用的文献
1
Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.
Int J Infect Dis. 2022 Jan;114:252-260. doi: 10.1016/j.ijid.2021.11.009. Epub 2021 Nov 17.
2
The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.
Lancet Glob Health. 2020 Oct;8(10):e1295-e1304. doi: 10.1016/S2214-109X(20)30357-0.
3
Reemerging Sudan Ebola virus disease in Uganda, 2011.
Emerg Infect Dis. 2012 Sep;18(9):1480-3. doi: 10.3201/eid1809.111536.
Zotero 插件